The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Depression
Interventions: DRUG: Melatonin (N-acetyl-5-methoxytryptamine)|DRUG: Placebo
Sponsor: Melissa Voigt Hansen
Collaborators: University of Copenhagen|Rigshospitalet, Denmark|Pharma Nord